
Megmastate 250mg Injection
Marketer
Ridhima Biocare
Salt Composition
Ethamsylate (250mg)
Overview Megmastate 250mg Injection
Hemostatin-250 Injection (250mg) effectively manages hemorrhaging. Its application encompasses the prevention and reduction of blood loss in scenarios such as menstrual irregularities and uterine bleeding disorders. Furthermore, it mitigates bleeding risk surrounding, preceding, or following sensitive surgical procedures. Hemostatin-250 functions as a hemostatic agent, enhancing platelet aggregation to facilitate clot formation and controlling capillary bleeding. Administration requires a healthcare provider's oversight, with close monitoring for allergic responses. Prior known allergy contraindicates use. Common, albeit generally mild, adverse effects may include skin rash, nausea, vomiting, headache, and injection site reactions; persistence or exacerbation warrants medical attention. Pregnant or breastfeeding individuals, and those with hepatic, renal, or cardiac compromise, should disclose this information to their physician before treatment. Complete medication disclosure, encompassing all concurrently used drugs, is also essential.
Primary Ingredients of Megmastate 250mg Injection
There is no text provided to rewrite.
Uses of Megmastate 250mg Injection
Managing Hemorrhage
Major Benefits of Megmastate 250mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
Common Side effects of Megmastate 250mg Injection:
- Skin rash
- Vomiting
- Headache
- Nausea
- Injection site reactions (pain, swelling, redness)
How to use Megmastate 250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Megmastate 250mg Injection works:
Hemostatin-250 Injection (250mg) promotes blood clotting. Its mechanism involves enhancing platelet aggregation, thereby facilitating clot formation and stemming capillary bleeding.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Megmastate 250mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnancy-related data on the administration of Megmastate 250mg Injection is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Megmastate 250mg Injection with breastfeeding are lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by a 250mg Megmastate injection.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Megmastate 250mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Megmastate 250mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Megmastate 250mg Injection :
Should you forget a dose of Megmastate 250mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Megmastate 250mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzenesulfonate-based compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Blood clotting agent |
